Wei Lin 4
4 · Erasca, Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Erasca, Inc.ERAS
Wei Lin
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+272,100→ 272,100 totalExercise: $11.54Exp: 2032-01-31→ Common Stock (272,100 underlying) - Other
Common Stock
2022-02-01$11.60/sh+1,562$18,123→ 314,062 total
Footnotes (2)
- [F1]Includes 1,562 shares acquired under the Erasca, Inc. employee stock purchase plan on December 15, 2021.
- [F2]1/48th of the shares subject to the option vest monthly following February 2, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.